The future of cell analysis.
At Rivercyte, we produce technology for the analysis of physical phenotypes of cells, including their deformability - information largely missing in current biological and medical research.
Our vision
We envision that in the future, insights about the physical phenotype of cells will be informing decisions in clinical practice.
Our mission
We aim to democratize the technology for physical phenotyping of cells. We strive to make it widely available by offering affordable devices and consumables.
News
Rivercyte presents at MedtechSUMMIT 2024
2024-05-15
Our founders Shada Hofemeier Abuhattum and Martin Kräter presented the Naiad and our data analysis solutions at MedtechSUMMIT 2024 in Regensburg. The event, centered on "Digitale Diagnostik - Die transformative Kraft von KI in der Diagnostik?", highlighted AI's transformative impact on digital diagnostics, discussing challenges and innovative solutions.
Read more
Rivercyte showcases the Naiad at the “Mechanics of Life” symposium at EMBL Heidelberg
2024-04-18
Rivercyte showcased their Naiad device at the "Mechanics of Life" symposium at EMBL Heidelberg, demonstrating their deformability cytometry technology. The symposium, focused on the role of mechanical forces from molecules to organs in development and disease, was attended by an interdisciplinary audience. Rivercyte cofounders Martin Kräter and Markéta Kubánková presented projects on deformability cytometry, including a method for diagnosing colon cancer biopsies using AI and TissueGrinder.
Read more
Tumour biopsy diagnostics using physical phenotyping of cells from tissues - new article out in Nature Biomedical Engineering
2023-02-09
In this article published in Nature Biomedical Engineering, Soteriou and Kubankova et al. demonstrate the potential of physical phenotyping of cells for tumour biopsy diagnostics. With this approach, the physical phenotypes of singularised suspended cells dissociated from the tissue biopsy samples are analysed within 30 minutes. This sets the grounds for a new alternative to histopathological consultation during surgery, reducing time, labour and costs spent.
Read more